share_log

Rigel Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Master Fund, L.P.(5.4%),Soleus Capital, LLC(5.4%), etc.

Rigel Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Soleus Capital Master Fund, L.P.(5.4%),Soleus Capital, LLC(5.4%)等

SEC announcement ·  02/02 10:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息